(NASDAQ: AWH) Aspira Women's Health's forecast annual revenue growth rate of 5.7% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -4.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 29.08%.
Aspira Women's Health's revenue in 2023 is $9,177,000.On average, 1 Wall Street analysts forecast AWH's revenue for 2023 to be $100,267,290, with the lowest AWH revenue forecast at $100,267,290, and the highest AWH revenue forecast at $100,267,290.
In 2024, AWH is forecast to generate $139,547,259 in revenue, with the lowest revenue forecast at $139,547,259 and the highest revenue forecast at $139,547,259.